Suppr超能文献

富血小板产品补充与未补充情况下关节镜修复全层肩袖撕裂后的临床和结构结果:一项荟萃分析和元回归分析

Clinical and structural outcomes after arthroscopic repair of full-thickness rotator cuff tears with and without platelet-rich product supplementation: a meta-analysis and meta-regression.

作者信息

Warth Ryan J, Dornan Grant J, James Evan W, Horan Marilee P, Millett Peter J

机构信息

Steadman Philippon Research Institute, Vail, Colorado, U.S.A.

Steadman Philippon Research Institute, Vail, Colorado, U.S.A.; The Steadman Clinic, Vail, Colorado, U.S.A..

出版信息

Arthroscopy. 2015 Feb;31(2):306-20. doi: 10.1016/j.arthro.2014.09.007. Epub 2014 Nov 14.

Abstract

PURPOSE

The purpose of this study was to perform a systematic review, meta-analysis, and meta-regression of all Level I and Level II studies comparing the clinical or structural outcomes, or both, after rotator cuff repair with and without platelet-rich product (PRP) supplementation.

METHODS

A literature search of the PubMed and EMBASE databases was performed to identify all Level I or II studies comparing the clinical or structural outcomes, or both, after arthroscopic repair of full-thickness rotator cuff tears with (PRP+ group) and without (PRP- group) PRP supplementation. Data included outcome scores (American Shoulder and Elbow Surgeons [ASES], University of California Los Angeles [UCLA], Constant, Simple Shoulder Test [SST] and visual analog scale [VAS] scores) and retears diagnosed with imaging studies. Meta-analyses compared preoperative, postoperative, and gain in outcome scores and relative risk ratios for retears. Meta-regression compared the effect of PRP treatment on outcome scores and retear rates according to 6 covariates. Minimum effect sizes that were detectable with 80% power were also calculated for each study.

RESULTS

Eleven studies were included in this review and a maximum of 8 studies were used for meta-analyses according to data availability. There were no statistically significant differences between the PRP+ and PRP- groups for overall outcome scores or retear rates (P > .05). Overall gain in the Constant score was decreased when liquid PRP was injected over the tendon surface compared with PRP application at the tendon-bone interface (-6.88 points v +0.78 points, respectively; P = .046); however, this difference did not reach the previously reported minimum clinically important difference (MCID) for Constant scores. When the initial tear size was greater than 3 cm in anterior-posterior length, the PRP+ group exhibited decreased retear rates after double-row repairs when compared with the PRP- group (25.9% v 57.1%, respectively; P = .046). Sensitivity power analyses revealed that most included studies were only powered to detect large differences in outcome scores between groups.

CONCLUSIONS

There were no statistically significant differences in overall gain in outcome scores or retear rates between treatment groups. Gain in Constant scores was significantly increased when PRPs were applied at the tendon-bone interface when compared with application over the top of the repaired tendon. Retear rates were significantly decreased when PRPs were used for the treatment of tears greater than 3 cm in anterior-posterior length using a double-row technique. Most of the included studies were only powered to detect large differences in outcome scores between treatment groups. In addition, an increased risk for selection, performance, and attrition biases was found.

LEVEL OF EVIDENCE

Level II, meta-analysis of Level I and Level II studies.

摘要

目的

本研究旨在对所有I级和II级研究进行系统评价、荟萃分析和荟萃回归,比较补充富血小板产品(PRP)与未补充PRP的肩袖修复术后的临床或结构结局,或两者兼而有之。

方法

对PubMed和EMBASE数据库进行文献检索,以识别所有I级或II级研究,这些研究比较了关节镜下修复全层肩袖撕裂后补充PRP(PRP+组)和未补充PRP(PRP-组)的临床或结构结局,或两者兼而有之。数据包括结局评分(美国肩肘外科医师学会[ASES]、加利福尼亚大学洛杉矶分校[UCLA]、Constant、简单肩袖试验[SST]和视觉模拟量表[VAS]评分)以及影像学研究诊断的再撕裂情况。荟萃分析比较了术前、术后和结局评分的增加以及再撕裂的相对风险比。荟萃回归根据6个协变量比较了PRP治疗对结局评分和再撕裂率的影响。还为每项研究计算了具有80%检验效能时可检测到的最小效应量。

结果

本综述纳入了11项研究,根据数据可用性,最多8项研究用于荟萃分析。PRP+组和PRP-组在总体结局评分或再撕裂率方面无统计学显著差异(P>.05)。与在肌腱-骨界面应用PRP相比,在肌腱表面注射液体PRP时,Constant评分的总体增加有所降低(分别为-6.88分和+0.78分;P=.046);然而,这种差异未达到先前报道的Constant评分的最小临床重要差异(MCID)。当最初撕裂的前后长度大于3 cm时,与PRP-组相比,PRP+组在双排修复后的再撕裂率降低(分别为25.9%和57.1%;P=.046)。敏感性效能分析显示,大多数纳入研究仅具有检测组间结局评分大差异的效能。

结论

治疗组在结局评分的总体增加或再撕裂率方面无统计学显著差异。与在修复肌腱顶部应用PRP相比,在肌腱-骨界面应用PRP时,Constant评分显著增加。当使用双排技术将PRP用于治疗前后长度大于3 cm的撕裂时,再撕裂率显著降低。大多数纳入研究仅具有检测治疗组间结局评分大差异的效能。此外,发现选择、实施和失访偏倚的风险增加。

证据级别

II级,I级和II级研究的荟萃分析。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验